Citation Impact
Citing Papers
Matrix Protein CCN1 Is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis
2009 Standout
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Seminal oxidative stress in patients with chronic prostatitis
2000
Prostate cancer
2008
Spotlight on Bicalutamide 150mg in the Treatment of Locally Advanced Prostate Cancer1
2007
Bicalutamide (Casodex®) in the treatment of prostate cancer
2004
Inflammation in prostate carcinogenesis
2007
Electrochemiluminescent behavior of allopurinol in the presence of Ru(bpy)32+
2005
Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles
2011
Exosomes: Extracellular organelles important in intercellular communication
2010 Standout
Epidemiology of Prostate Cancer
2019 Standout
Expression of Prostasome-like Granules by the Prostate Cancer Cell Lines PC3, Dul45 and LnCaP Grown in Monolayer
1999
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
2005
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
2016
Prostasome‐like particles are involved in the transfer of P25b from the bovine epididymal fluid to the sperm surface
2001
Osmoregulation and Excretion
2014
EAU Guidelines on Prostate Cancer
2007 Standout
Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction
2016
Role of reactive oxygen species in the pathophysiology of human reproduction
2003 Standout
Peptide drugs to target G protein-coupled receptors
2010
The Future of Peptide‐based Drugs
2012 Standout
Prostasomes are mediators of intercellular communication: from basic research to clinical implications
2011
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia
2004
Microneedles for drug and vaccine delivery
2012 Standout
Structural heterogeneity and protein composition of exosome‐like vesicles (prostasomes) in human semen
2008
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Exosomes: composition, biogenesis and function
2002 Standout
A review on therapeutic potential of Nigella sativa: A miracle herb
2013 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
2013
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Prostatitis
1998
Exosomes
2019 Standout
Water as an Active Constituent in Cell Biology
2007 Standout
A review of recent advances and future challenges in freshwater salinization
2020 Standout
Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinical Trials of Degarelix
2011
Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer
2011
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Desiccation tolerance of prokaryotes
1994 Standout
LIMITATIONS IN THE USE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS TO MONITOR PATIENTS AFTER TREATMENT FOR PROSTATE CANCER
2005
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
2005
Role of water in some biological processes
1990
Volume of Ambulatory Care Visits and Patterns of Care for Patients Diagnosed with Plantar Fasciitis: A National Study of Medical Doctors
2004 Standout
BICALUTAMIDE 150 MG MAINTAINS BONE MINERAL DENSITY DURING MONOTHERAPY FOR LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER
2004
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
HOW COMMON IS PROSTATITIS? A NATIONAL SURVEY OF PHYSICIAN VISITS
1998
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
GYNECOMASTIA AND BREAST PAIN INDUCED BY ADJUVANT THERAPY WITH BICALUTAMIDE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PROSTATE CANCER: THE ROLE OF TAMOXIFEN AND RADIOTHERAPY
2005
The relationship between liquid, supercooled and glassy water
1998 StandoutNature
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy
2004
Methanolic Extract of Nigella sativa Seeds is Potent Clonogenic Inhibitor of PC3 Cells
2008
Bicalutamide Monotherapy Versus Leuprolide Monotherapy for Prostate Cancer: Effects on Bone Mineral Density and Body Composition
2004
Evaluation of Tamoxifen and Anastrozole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Cancer
2005
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
2006
Cancer de la prostate
2007
Traditional androgen ablation approaches to advanced prostate cancer: new insights.
2014
Works of Bo‐Eric Persson being referenced
A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
2011
Dynamics of glomerular ultrafiltration in Amphiuma means
1981
The existence of a tubulo-glomerular feedback mechanism in the Amphiuma nephron
1981
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
2008
Allopurinol Treatment Results inElevated Prostate-Specific AntigenLevels in Prostatic Fluid and Serumof Patients with Non-BacterialProstatitis
1996
Monoclonal antibodies against human prostasomes
1998
Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics
2009
Long-term Tolerability and Efficacy of Degarelix: 5-Year Results From a Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix
2014
Carbonic anhydrase inhibition and cell volume regulation in Necturus gallbladder
1986
A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America
2008
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program
2002
Evidence for a Mechanistic Association Between Nonbacterial Prostatitis and Levels of Urate and Creatinine in Expressed Prostatic Secretion
1996
Ameliorative Effect of Allopurinol on Nonbacterial Prostatitis: A Parallel Double-Blind Controlled Study
1996
Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer
2010